BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 12360485)

  • 21. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
    Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
    Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
    Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
    BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats.
    Aldemir M; Geyik MF; Kökoğlu OF; Büyükbayram H; Hoşoğlu S; Yağmur Y
    ANZ J Surg; 2003 Sep; 73(9):722-6. PubMed ID: 12956789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.
    Voshol PJ; Koopen NR; de Vree JM; Havinga R; Princen HM; Elferink RP; Groen AK; Kuipers F
    J Hepatol; 2001 Feb; 34(2):202-9. PubMed ID: 11281547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
    Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
    Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New therapeutical indications of ursodeoxycholic acid.
    Copaci I; Micu L; Iliescu L; Voiculescu M
    Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease.
    Pradhan-Sundd T; Kosar K; Saggi H; Zhang R; Vats R; Cornuet P; Green S; Singh S; Zeng G; Sundd P; Nejak-Bowen K
    Hepatology; 2020 May; 71(5):1732-1749. PubMed ID: 31489648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
    Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
    Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress.
    Chen HL; Chen HL; Yuan RH; Wu SH; Chen YH; Chien CS; Chou SP; Wang R; Ling V; Chang MH
    J Cell Mol Med; 2012 Nov; 16(11):2679-89. PubMed ID: 22564513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
    Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
    J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.
    Barone M; Maiorano E; Ladisa R; Pece A; Berloco P; Strazzabosco M; Caruso ML; Valentini AM; Ierardi E; Di Leo A; Francavilla A
    Virchows Arch; 2004 Jun; 444(6):554-60. PubMed ID: 15071740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
    Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
    Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.
    Fiorotto R; Spirlì C; Fabris L; Cadamuro M; Okolicsanyi L; Strazzabosco M
    Gastroenterology; 2007 Nov; 133(5):1603-13. PubMed ID: 17983806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
    J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of ursodeoxycholic acid in patients with liver disease.
    Angulo P
    Curr Gastroenterol Rep; 2002 Feb; 4(1):37-44. PubMed ID: 11825540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockout of the Tachykinin Receptor 1 in the Mdr2
    Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
    Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
    Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
    J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    He H; Mennone A; Boyer JL; Cai SY
    Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of ursodeoxycholic acid- and canrenoate-induced biliary bicarbonate secretion and the effect on glucose- and amino acid-induced cholestasis.
    Omland E; Mathisen O
    Scand J Gastroenterol; 1991 May; 26(5):513-22. PubMed ID: 1871544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.